長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4554】富士製薬工業

【4554】富士製薬工業
ジェネリック医薬品。大株主に三井物産。
類似企業：


東証プライム
医薬
＞
ジェ
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.09 2024/11/12 当初予 53,360 - - - 4,850 - - - 4,680 - - - 3,380 - - -
2024.09 2024/11/12 実 46,138 ↑ +0.2% -5.7% 3,880 ↓ -2.8% -20.9% 4,445 ↓ -3.4% -20.1% 6,146 ↓ -0.6% +53.1%
2024.09 2024/08/08 Q3予 46,060 → 0.0% -5.9% 3,990 → 0.0% -18.7% 4,602 → 0.0% -17.3% 6,185 → 0.0% +54.0%
2024.09 2024/05/09 Q2予 46,060 ↓ -5.9% -5.9% 3,990 ↓ -18.7% -18.7% 4,602 ↓ -17.3% -17.3% 6,185 → 0.0% +54.0%
2024.09 2024/02/08 Q1予 48,926 → 0.0% 0.0% 4,907 → 0.0% 0.0% 5,562 → 0.0% 0.0% 6,185 → 0.0% +54.0%
2024.09 2023/11/27 修正予 48,926 → 0.0% 0.0% 4,907 → 0.0% 0.0% 5,562 → 0.0% 0.0% 6,185 ↑ +54.0% +54.0%
2024.09 2023/11/09 当初予 48,926 - - - 4,907 - - - 5,562 - - - 4,015 - - -
2023.09 2023/11/09 実 40,889 ↓ -5.6% -5.6% 3,858 ↓ -4.7% -4.7% 4,519 ↑ +10.5% +10.5% 3,435 ↑ +15.5% +15.5%
2023.09 2023/08/08 Q3予 43,311 → 0.0% 0.0% 4,048 → 0.0% 0.0% 4,088 → 0.0% 0.0% 2,974 → 0.0% 0.0%
2023.09 2023/05/11 Q2予 43,311 → 0.0% 0.0% 4,048 → 0.0% 0.0% 4,088 → 0.0% 0.0% 2,974 → 0.0% 0.0%
2023.09 2023/02/09 Q1予 43,311 → 0.0% 0.0% 4,048 → 0.0% 0.0% 4,088 → 0.0% 0.0% 2,974 → 0.0% 0.0%
2023.09 2022/11/10 当初予 43,311 - - - 4,048 - - - 4,088 - - - 2,974 - - -
2022.09 2022/11/10 実 35,426 → 0.0% -1.5% 3,777 → 0.0% +8.2% 3,725 → 0.0% +5.2% 2,696 ↓ -3.3% +5.2%
2022.09 2022/11/02 修正予 35,426 ↓ -1.5% -1.5% 3,777 ↑ +8.2% +8.2% 3,725 ↑ +5.2% +5.2% 2,787 ↑ +8.8% +8.8%
2022.09 2022/08/05 Q3予 35,966 → 0.0% 0.0% 3,490 → 0.0% 0.0% 3,540 → 0.0% 0.0% 2,562 → 0.0% 0.0%
2022.09 2022/05/06 Q2予 35,966 → 0.0% 0.0% 3,490 → 0.0% 0.0% 3,540 → 0.0% 0.0% 2,562 → 0.0% 0.0%
2022.09 2022/02/04 Q1予 35,966 → 0.0% 0.0% 3,490 → 0.0% 0.0% 3,540 → 0.0% 0.0% 2,562 → 0.0% 0.0%
2022.09 2021/11/05 当初予 35,966 - - - 3,490 - - - 3,540 - - - 2,562 - - -
2021.09 2021/11/05 実 33,990 ↓ -2.1% -2.1% 3,349 ↑ +17.2% +17.2% 3,250 ↑ +15.8% +15.8% 2,432 ↑ +15.8% +15.8%
2021.09 2021/08/05 Q3予 34,702 → 0.0% 0.0% 2,857 → 0.0% 0.0% 2,807 → 0.0% 0.0% 2,100 → 0.0% 0.0%
2021.09 2021/02/04 Q1予 34,702 → 0.0% 0.0% 2,857 → 0.0% 0.0% 2,807 → 0.0% 0.0% 2,100 → 0.0% 0.0%
2021.09 2020/11/05 当初予 34,702 - - - 2,857 - - - 2,807 - - - 2,100 - - -
2020.09 2020/11/05 実 33,793 ↓ -0.1% -0.1% 3,139 ↑ +22.1% +22.1% 2,983 ↑ +19.3% +19.3% 2,085 ↑ +25.3% +25.3%
2020.09 2020/08/06 Q3予 33,830 → 0.0% 0.0% 2,571 → 0.0% 0.0% 2,501 → 0.0% 0.0% 1,664 → 0.0% 0.0%
2020.09 2020/07/01 修正予 33,830 → 0.0% 0.0% 2,571 → 0.0% 0.0% 2,501 → 0.0% 0.0% 1,664 ↑ +238.2% 0.0%
2020.09 2020/05/08 修正予 33,830 → 0.0% 0.0% 2,571 → 0.0% 0.0% 2,501 → 0.0% 0.0% 492 ↓ -70.4% -70.4%
2020.09 2020/02/06 Q1予 33,830 → 0.0% 0.0% 2,571 → 0.0% 0.0% 2,501 → 0.0% 0.0% 1,664 → 0.0% 0.0%
2020.09 2019/11/08 当初予 33,830 - - - 2,571 - - - 2,501 - - - 1,664 - - -
2019.09 2019/11/08 実 36,279 ↓ -1.5% -1.5% 4,173 ↓ -8.0% -8.0% 4,169 ↓ -7.5% -7.5% 2,962 ↓ -12.8% -12.8%
2019.09 2019/08/08 Q3予 36,815 → 0.0% 0.0% 4,535 → 0.0% 0.0% 4,506 → 0.0% 0.0% 3,396 → 0.0% 0.0%
2019.09 2019/05/09 Q2予 36,815 → 0.0% 0.0% 4,535 → 0.0% 0.0% 4,506 → 0.0% 0.0% 3,396 → 0.0% 0.0%
2019.09 2019/02/07 Q1予 36,815 → 0.0% 0.0% 4,535 → 0.0% 0.0% 4,506 → 0.0% 0.0% 3,396 → 0.0% 0.0%
2019.09 2018/11/09 当初予 36,815 - - - 4,535 - - - 4,506 - - - 3,396 - - -
2018.09 2018/11/09 実 37,909 ↓ -0.6% -0.6% 4,391 ↓ -9.5% -9.5% 4,472 ↓ -5.1% -5.1% 3,372 ↑ +0.8% +0.8%
2018.09 2018/08/09 Q3予 38,139 → 0.0% 0.0% 4,850 → 0.0% 0.0% 4,710 → 0.0% 0.0% 3,345 → 0.0% 0.0%
2018.09 2018/05/10 Q2予 38,139 → 0.0% 0.0% - - - - 4,710 → 0.0% 0.0% 3,345 → 0.0% 0.0%
2018.09 2018/02/08 Q1予 38,139 → 0.0% 0.0% 4,850 → 0.0% 0.0% 4,710 → 0.0% 0.0% 3,345 → 0.0% 0.0%
2018.09 2017/11/10 当初予 38,139 - - - 4,850 - - - 4,710 - - - 3,345 - - -
2017.09 2017/11/10 実 35,387 ↓ -2.5% -2.5% 4,314 ↑ +0.3% +0.3% 4,628 ↑ +10.7% +10.7% 3,301 ↑ +17.9% +17.9%
2017.09 2017/08/08 Q3予 36,300 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,180 → 0.0% 0.0% 2,800 → 0.0% 0.0%
2017.09 2017/05/10 Q2予 36,300 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,180 → 0.0% 0.0% 2,800 → 0.0% 0.0%
2017.09 2017/02/08 Q1予 36,300 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,180 → 0.0% 0.0% 2,800 → 0.0% 0.0%
2017.09 2016/11/11 当初予 36,300 - - - 4,300 - - - 4,180 - - - 2,800 - - -
2016.09 2016/11/11 実 34,229 ↓ -0.7% -0.7% 3,568 ↑ +2.5% +2.5% 3,251 ↓ -5.2% -5.2% 2,118 ↓ -5.0% -5.0%
2016.09 2016/08/09 Q3予 34,470 → 0.0% 0.0% 3,480 → 0.0% 0.0% 3,430 → 0.0% 0.0% 2,230 → 0.0% 0.0%
2016.09 2016/05/12 Q2予 34,470 → 0.0% 0.0% 3,480 → 0.0% 0.0% 3,430 → 0.0% 0.0% 2,230 → 0.0% 0.0%
2016.09 2016/02/09 Q1予 34,470 → 0.0% 0.0% 3,480 → 0.0% 0.0% 3,430 → 0.0% 0.0% 2,230 → 0.0% 0.0%
2016.09 2015/11/13 当初予 34,470 - - - 3,480 - - - 3,430 - - - 2,230 - - -
2015.09 2015/11/13 実 31,680 ↓ -1.1% -1.1% 3,251 ↓ -9.4% -9.4% 3,099 ↓ -12.9% -12.9% 2,092 ↓ -7.4% -7.4%
2015.09 2015/08/07 Q3予 32,030 → 0.0% 0.0% 3,590 → 0.0% 0.0% 3,560 → 0.0% 0.0% 2,260 → 0.0% 0.0%
2015.09 2015/05/13 Q2予 32,030 → 0.0% 0.0% 3,590 → 0.0% 0.0% 3,560 → 0.0% 0.0% 2,260 → 0.0% 0.0%
2015.09 2015/02/10 Q1予 32,030 → 0.0% 0.0% 3,590 → 0.0% 0.0% 3,560 → 0.0% 0.0% 2,260 → 0.0% 0.0%
2015.09 2014/11/14 当初予 32,030 - - - 3,590 - - - 3,560 - - - 2,260 - - -
2014.09 2014/11/14 実 29,215 - - - 3,173 - - - 3,198 - - - 2,078 - - -
シェア ツイート
ページトップへ戻る